Industry Research Reports
Home > Reports > Chemical & Material > Global L-Leucine Market Outlook, In‑Depth Analysis & Forecast to 2031
Global L-Leucine Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 169 Pages
Report ld: 5278235
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global L-Leucine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
From a downstream perspective, Feed Industry accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
L-Leucine leading manufacturers including Ajinomoto, Evonik, Kyowa Hakko, Amino, Luzhou Group, Meihua Group, Shine Star Biological, Sanxia Pharmaceutical, Xinhanling Bol-Engineering, Jinghai Amino Acid, etc., dominate supply; the top five capture approximately % of global revenue, with Ajinomoto leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global L-Leucine market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ajinomoto
- Evonik
- Kyowa Hakko
- Amino
- Luzhou Group
- Meihua Group
- Shine Star Biological
- Sanxia Pharmaceutical
- Xinhanling Bol-Engineering
- Jinghai Amino Acid
- Jiahe Biotech
- Vega Group
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Feed Grade
- Food Grade
- Pharmaceutical Grade
Segment by Application
- Feed Industry
- Food Industry
- Pharmaceutical Industry
CHAPTER OUTLINE
Chapter 1: Defines the L-Leucine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to L-Leucine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global L-Leucine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Feed Grade
1.2.3 Food Grade
1.2.4 Pharmaceutical Grade
1.3 Market Segmentation by Application
1.3.1 Global L-Leucine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Feed Industry
1.3.3 Food Industry
1.3.4 Pharmaceutical Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global L-Leucine Revenue Estimates and Forecasts 2020-2031
2.2 Global L-Leucine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global L-Leucine Sales Estimates and Forecasts 2020-2031
2.4 Global L-Leucine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global L-Leucine Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global L-Leucine Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global L-Leucine Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Feed Grade Market Size by Manufacturers
4.5.2 Food Grade Market Size by Manufacturers
4.5.3 Pharmaceutical Grade Market Size by Manufacturers
4.6 Global L-Leucine Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global L-Leucine Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global L-Leucine Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global L-Leucine Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global L-Leucine Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America L-Leucine Sales and Revenue by Type (2020-2031)
7.4 North America L-Leucine Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America L-Leucine Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe L-Leucine Sales and Revenue by Type (2020-2031)
8.4 Europe L-Leucine Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe L-Leucine Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific L-Leucine Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific L-Leucine Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific L-Leucine Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America L-Leucine Sales and Revenue by Type (2020-2031)
10.4 Central and South America L-Leucine Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America L-Leucine Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa L-Leucine Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa L-Leucine Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa L-Leucine Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Ajinomoto
12.1.1 Ajinomoto Corporation Information
12.1.2 Ajinomoto Business Overview
12.1.3 Ajinomoto L-Leucine Product Models, Descriptions and Specifications
12.1.4 Ajinomoto L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ajinomoto L-Leucine Sales by Product in 2024
12.1.6 Ajinomoto L-Leucine Sales by Application in 2024
12.1.7 Ajinomoto L-Leucine Sales by Geographic Area in 2024
12.1.8 Ajinomoto L-Leucine SWOT Analysis
12.1.9 Ajinomoto Recent Developments
12.2 Evonik
12.2.1 Evonik Corporation Information
12.2.2 Evonik Business Overview
12.2.3 Evonik L-Leucine Product Models, Descriptions and Specifications
12.2.4 Evonik L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Evonik L-Leucine Sales by Product in 2024
12.2.6 Evonik L-Leucine Sales by Application in 2024
12.2.7 Evonik L-Leucine Sales by Geographic Area in 2024
12.2.8 Evonik L-Leucine SWOT Analysis
12.2.9 Evonik Recent Developments
12.3 Kyowa Hakko
12.3.1 Kyowa Hakko Corporation Information
12.3.2 Kyowa Hakko Business Overview
12.3.3 Kyowa Hakko L-Leucine Product Models, Descriptions and Specifications
12.3.4 Kyowa Hakko L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Kyowa Hakko L-Leucine Sales by Product in 2024
12.3.6 Kyowa Hakko L-Leucine Sales by Application in 2024
12.3.7 Kyowa Hakko L-Leucine Sales by Geographic Area in 2024
12.3.8 Kyowa Hakko L-Leucine SWOT Analysis
12.3.9 Kyowa Hakko Recent Developments
12.4 Amino
12.4.1 Amino Corporation Information
12.4.2 Amino Business Overview
12.4.3 Amino L-Leucine Product Models, Descriptions and Specifications
12.4.4 Amino L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Amino L-Leucine Sales by Product in 2024
12.4.6 Amino L-Leucine Sales by Application in 2024
12.4.7 Amino L-Leucine Sales by Geographic Area in 2024
12.4.8 Amino L-Leucine SWOT Analysis
12.4.9 Amino Recent Developments
12.5 Luzhou Group
12.5.1 Luzhou Group Corporation Information
12.5.2 Luzhou Group Business Overview
12.5.3 Luzhou Group L-Leucine Product Models, Descriptions and Specifications
12.5.4 Luzhou Group L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Luzhou Group L-Leucine Sales by Product in 2024
12.5.6 Luzhou Group L-Leucine Sales by Application in 2024
12.5.7 Luzhou Group L-Leucine Sales by Geographic Area in 2024
12.5.8 Luzhou Group L-Leucine SWOT Analysis
12.5.9 Luzhou Group Recent Developments
12.6 Meihua Group
12.6.1 Meihua Group Corporation Information
12.6.2 Meihua Group Business Overview
12.6.3 Meihua Group L-Leucine Product Models, Descriptions and Specifications
12.6.4 Meihua Group L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Meihua Group Recent Developments
12.7 Shine Star Biological
12.7.1 Shine Star Biological Corporation Information
12.7.2 Shine Star Biological Business Overview
12.7.3 Shine Star Biological L-Leucine Product Models, Descriptions and Specifications
12.7.4 Shine Star Biological L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shine Star Biological Recent Developments
12.8 Sanxia Pharmaceutical
12.8.1 Sanxia Pharmaceutical Corporation Information
12.8.2 Sanxia Pharmaceutical Business Overview
12.8.3 Sanxia Pharmaceutical L-Leucine Product Models, Descriptions and Specifications
12.8.4 Sanxia Pharmaceutical L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Sanxia Pharmaceutical Recent Developments
12.9 Xinhanling Bol-Engineering
12.9.1 Xinhanling Bol-Engineering Corporation Information
12.9.2 Xinhanling Bol-Engineering Business Overview
12.9.3 Xinhanling Bol-Engineering L-Leucine Product Models, Descriptions and Specifications
12.9.4 Xinhanling Bol-Engineering L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Xinhanling Bol-Engineering Recent Developments
12.10 Jinghai Amino Acid
12.10.1 Jinghai Amino Acid Corporation Information
12.10.2 Jinghai Amino Acid Business Overview
12.10.3 Jinghai Amino Acid L-Leucine Product Models, Descriptions and Specifications
12.10.4 Jinghai Amino Acid L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Jinghai Amino Acid Recent Developments
12.11 Jiahe Biotech
12.11.1 Jiahe Biotech Corporation Information
12.11.2 Jiahe Biotech Business Overview
12.11.3 Jiahe Biotech L-Leucine Product Models, Descriptions and Specifications
12.11.4 Jiahe Biotech L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Jiahe Biotech Recent Developments
12.12 Vega Group
12.12.1 Vega Group Corporation Information
12.12.2 Vega Group Business Overview
12.12.3 Vega Group L-Leucine Product Models, Descriptions and Specifications
12.12.4 Vega Group L-Leucine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Vega Group Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 L-Leucine Industry Chain
13.2 L-Leucine Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 L-Leucine Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 L-Leucine Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 L-Leucine Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global L-Leucine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global L-Leucine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global L-Leucine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global L-Leucine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global L-Leucine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global L-Leucine Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global L-Leucine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global L-Leucine Sales by Region (2020-2025) & (K MT)
Table 8. Global L-Leucine Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global L-Leucine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global L-Leucine Production by Region (2020-2025) & (K MT)
Table 12. Global L-Leucine Production by Region (2026-2031) & (K MT)
Table 13. Global L-Leucine Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global L-Leucine Sales Share by Manufacturers (2020-2025)
Table 15. Global L-Leucine Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global L-Leucine Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global L-Leucine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in L-Leucine as of 2024)
Table 19. Global L-Leucine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global L-Leucine Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers L-Leucine Manufacturing Base and Headquarters
Table 22. Global L-Leucine Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global L-Leucine Sales by Type (2020-2025) & (K MT)
Table 26. Global L-Leucine Sales by Type (2026-2031) & (K MT)
Table 27. Global L-Leucine Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global L-Leucine Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global L-Leucine ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global L-Leucine Sales by Application (2020-2025) & (K MT)
Table 32. Global L-Leucine Sales by Application (2026-2031) & (K MT)
Table 33. L-Leucine High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global L-Leucine Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global L-Leucine Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global L-Leucine ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America L-Leucine Growth Accelerators and Market Barriers
Table 40. North America L-Leucine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America L-Leucine Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe L-Leucine Growth Accelerators and Market Barriers
Table 43. Europe L-Leucine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe L-Leucine Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific L-Leucine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific L-Leucine Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific L-Leucine Growth Accelerators and Market Barriers
Table 48. Southeast Asia L-Leucine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America L-Leucine Investment Opportunities and Key Challenges
Table 50. Central and South America L-Leucine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa L-Leucine Investment Opportunities and Key Challenges
Table 52. Middle East and Africa L-Leucine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Ajinomoto Corporation Information
Table 54. Ajinomoto Description and Major Businesses
Table 55. Ajinomoto Product Models, Descriptions and Specifications
Table 56. Ajinomoto Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Ajinomoto Sales Value Proportion by Product in 2024
Table 58. Ajinomoto Sales Value Proportion by Application in 2024
Table 59. Ajinomoto Sales Value Proportion by Geographic Area in 2024
Table 60. Ajinomoto L-Leucine SWOT Analysis
Table 61. Ajinomoto Recent Developments
Table 62. Evonik Corporation Information
Table 63. Evonik Description and Major Businesses
Table 64. Evonik Product Models, Descriptions and Specifications
Table 65. Evonik Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. Evonik Sales Value Proportion by Product in 2024
Table 67. Evonik Sales Value Proportion by Application in 2024
Table 68. Evonik Sales Value Proportion by Geographic Area in 2024
Table 69. Evonik L-Leucine SWOT Analysis
Table 70. Evonik Recent Developments
Table 71. Kyowa Hakko Corporation Information
Table 72. Kyowa Hakko Description and Major Businesses
Table 73. Kyowa Hakko Product Models, Descriptions and Specifications
Table 74. Kyowa Hakko Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Kyowa Hakko Sales Value Proportion by Product in 2024
Table 76. Kyowa Hakko Sales Value Proportion by Application in 2024
Table 77. Kyowa Hakko Sales Value Proportion by Geographic Area in 2024
Table 78. Kyowa Hakko L-Leucine SWOT Analysis
Table 79. Kyowa Hakko Recent Developments
Table 80. Amino Corporation Information
Table 81. Amino Description and Major Businesses
Table 82. Amino Product Models, Descriptions and Specifications
Table 83. Amino Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Amino Sales Value Proportion by Product in 2024
Table 85. Amino Sales Value Proportion by Application in 2024
Table 86. Amino Sales Value Proportion by Geographic Area in 2024
Table 87. Amino L-Leucine SWOT Analysis
Table 88. Amino Recent Developments
Table 89. Luzhou Group Corporation Information
Table 90. Luzhou Group Description and Major Businesses
Table 91. Luzhou Group Product Models, Descriptions and Specifications
Table 92. Luzhou Group Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Luzhou Group Sales Value Proportion by Product in 2024
Table 94. Luzhou Group Sales Value Proportion by Application in 2024
Table 95. Luzhou Group Sales Value Proportion by Geographic Area in 2024
Table 96. Luzhou Group L-Leucine SWOT Analysis
Table 97. Luzhou Group Recent Developments
Table 98. Meihua Group Corporation Information
Table 99. Meihua Group Description and Major Businesses
Table 100. Meihua Group Product Models, Descriptions and Specifications
Table 101. Meihua Group Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Meihua Group Recent Developments
Table 103. Shine Star Biological Corporation Information
Table 104. Shine Star Biological Description and Major Businesses
Table 105. Shine Star Biological Product Models, Descriptions and Specifications
Table 106. Shine Star Biological Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Shine Star Biological Recent Developments
Table 108. Sanxia Pharmaceutical Corporation Information
Table 109. Sanxia Pharmaceutical Description and Major Businesses
Table 110. Sanxia Pharmaceutical Product Models, Descriptions and Specifications
Table 111. Sanxia Pharmaceutical Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Sanxia Pharmaceutical Recent Developments
Table 113. Xinhanling Bol-Engineering Corporation Information
Table 114. Xinhanling Bol-Engineering Description and Major Businesses
Table 115. Xinhanling Bol-Engineering Product Models, Descriptions and Specifications
Table 116. Xinhanling Bol-Engineering Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Xinhanling Bol-Engineering Recent Developments
Table 118. Jinghai Amino Acid Corporation Information
Table 119. Jinghai Amino Acid Description and Major Businesses
Table 120. Jinghai Amino Acid Product Models, Descriptions and Specifications
Table 121. Jinghai Amino Acid Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Jinghai Amino Acid Recent Developments
Table 123. Jiahe Biotech Corporation Information
Table 124. Jiahe Biotech Description and Major Businesses
Table 125. Jiahe Biotech Product Models, Descriptions and Specifications
Table 126. Jiahe Biotech Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Jiahe Biotech Recent Developments
Table 128. Vega Group Corporation Information
Table 129. Vega Group Description and Major Businesses
Table 130. Vega Group Product Models, Descriptions and Specifications
Table 131. Vega Group Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Vega Group Recent Developments
Table 133. Key Raw Materials Distribution
Table 134. Raw Materials Key Suppliers
Table 135. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 136. Milestones in Production Technology Evolution
Table 137. Distributors List
Table 138. Market Trends and Market Evolution
Table 139. Market Drivers and Opportunities
Table 140. Market Challenges, Risks, and Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. L-Leucine Product Picture
Figure 2. Global L-Leucine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Feed Grade Product Picture
Figure 4. Food Grade Product Picture
Figure 5. Pharmaceutical Grade Product Picture
Figure 6. Global L-Leucine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Feed Industry
Figure 8. Food Industry
Figure 9. Pharmaceutical Industry
Figure 10. L-Leucine Report Years Considered
Figure 11. Global L-Leucine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 13. Global L-Leucine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global L-Leucine Revenue Market Share by Region (2020-2031)
Figure 15. Global L-Leucine Sales (2020-2031) & (K MT)
Figure 16. Global L-Leucine Sales (CAGR) by Region (2020-2031) (K MT)
Figure 17. Global L-Leucine Sales Market Share by Region (2020-2031)
Figure 18. Global L-Leucine Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 19. Global L-Leucine Production Trend by Region (2020-2031) (K MT)
Figure 20. Global L-Leucine Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. L-Leucine Production Growth Rate in North America (2020-2031) & (K MT)
Figure 23. L-Leucine Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 24. L-Leucine Production Growth Rate in China (2020-2031) & (K MT)
Figure 25. L-Leucine Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 26. Top 5 and Top 10 Manufacturers L-Leucine Sales Volume Market Share in 2024
Figure 27. Global L-Leucine Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Feed Grade Revenue Market Share by Manufacturer in 2024
Figure 30. Food Grade Revenue Market Share by Manufacturer in 2024
Figure 31. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global L-Leucine Sales Market Share by Type (2020-2031)
Figure 35. Global L-Leucine Revenue Market Share by Type (2020-2031)
Figure 36. Global L-Leucine Sales Market Share by Application (2020-2031)
Figure 37. Global L-Leucine Revenue Market Share by Application (2020-2031)
Figure 38. North America L-Leucine Sales YoY (2020-2031) & (K MT)
Figure 39. North America L-Leucine Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers L-Leucine Sales Revenue (US$ Million) in 2024
Figure 41. North America L-Leucine Sales Volume (K MT) by Type (2020- 2031)
Figure 42. North America L-Leucine Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America L-Leucine Sales Volume (K MT) by Application (2020-2031)
Figure 44. North America L-Leucine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 46. Canada L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 48. Europe L-Leucine Sales YoY (2020-2031) & (K MT)
Figure 49. Europe L-Leucine Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers L-Leucine Sales Revenue (US$ Million) in 2024
Figure 51. Europe L-Leucine Sales Volume (K MT) by Type (2020-2031)
Figure 52. Europe L-Leucine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe L-Leucine Sales Volume (K MT) by Application (2020-2031)
Figure 54. Europe L-Leucine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 56. France L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 58. Italy L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 59. Russia L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific L-Leucine Sales YoY (2020-2031) & (K MT)
Figure 61. Asia-Pacific L-Leucine Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers L-Leucine Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific L-Leucine Sales Volume (K MT) by Type (2020- 2031)
Figure 64. Asia-Pacific L-Leucine Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific L-Leucine Sales Volume (K MT) by Application (2020-2031)
Figure 66. Asia-Pacific L-Leucine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 68. Japan L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 71. India L-Leucine Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America L-Leucine Sales YoY (2020-2031) & (K MT)
Figure 73. Central and South America L-Leucine Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers L-Leucine Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America L-Leucine Sales Volume (K MT) by Type (2021-2031)
Figure 76. Central and South America L-Leucine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America L-Leucine Sales Volume (K MT) by Application (2020-2031)
Figure 78. Central and South America L-Leucine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa L-Leucine Sales YoY (2020-2031) & (K MT)
Figure 82. Middle East and Africa L-Leucine Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers L-Leucine Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa L-Leucine Sales Volume (K MT) by Type (2021-2031)
Figure 85. South America L-Leucine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa L-Leucine Sales Volume (K MT) by Application (2020-2031)
Figure 87. Middle East and Africa L-Leucine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa L-Leucine Revenue (2020-2025) & (US$ Million)
Figure 92. L-Leucine Industry Chain Mapping
Figure 93. Regional L-Leucine Manufacturing Base Distribution (%)
Figure 94. L-Leucine Production Process
Figure 95. Regional L-Leucine Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global L-Leucine market?
The top companies in the global L-Leucine market are Ajinomoto、Evonik、Kyowa Hakko.
Related Reports
L-Leucine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for L-Leucine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 145
USD 3950.00
(Single User License)
Global L-Leucine Market Research Report 2026
The global L-Leucine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 143
USD 2900.00
(Single User License)
Global L-Leucine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global L-Leucine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 92
USD 4250.00
(Single User License)
L-Leucine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for L-Leucine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 125
USD 3950.00
(Single User License)
Global L-Leucine Market Research Report 2025
The global market for L-Leucine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 100
USD 2900.00
(Single User License)
Global L-Leucine Market Insights, Forecast to 2030
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published Date: 2024-04-12
Pages: 114
USD 4900.00
(Single User License)
L-Leucine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published Date: 2024-01-24
Pages: 127
USD 3950.00
(Single User License)
Global L-Leucine Market Research Report 2024
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published Date: 2024-01-16
Pages: 102
USD 2900.00
(Single User License)
L-Leucine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for L-Leucine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 145
USD 3950.00 (Single User License)Global L-Leucine Market Research Report 2026
The global L-Leucine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 143
USD 2900.00 (Single User License)Global L-Leucine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global L-Leucine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 92
USD 4250.00 (Single User License)L-Leucine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for L-Leucine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 125
USD 3950.00 (Single User License)Global L-Leucine Market Research Report 2025
The global market for L-Leucine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 100
USD 2900.00 (Single User License)Global L-Leucine Market Insights, Forecast to 2030
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published: 2024-04-12
Pages: 114
USD 4900.00 (Single User License)L-Leucine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published: 2024-01-24
Pages: 127
USD 3950.00 (Single User License)Global L-Leucine Market Research Report 2024
L-leucine is an essential amino acid that is used in the biosynthesis of proteins. It is one of the three branched chain amino acids, along with L-isoleucine and L-valine. L-leucine is important for regulating the blood-sugar levels, promoting the growth and the recovery of muscle and bone tissues, and producing the growth hormone41. It is present in every cell in the body and is a key component of mitochondria, the energy regulators of the body.
Published: 2024-01-16
Pages: 102
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now